

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 7.61889538 |
| 2 | protein retention in ER lumen (GO:0006621) | 6.67327920 |
| 3 | COPII vesicle coating (GO:0048208) | 5.90946845 |
| 4 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.73791314 |
| 5 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.55204573 |
| 6 | positive regulation of nuclease activity (GO:0032075) | 5.48659251 |
| 7 | signal peptide processing (GO:0006465) | 5.34900330 |
| 8 | regulation of nuclease activity (GO:0032069) | 5.04552216 |
| 9 | protein maturation by protein folding (GO:0022417) | 4.99179120 |
| 10 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.85488714 |
| 11 | cellular response to unfolded protein (GO:0034620) | 4.75596583 |
| 12 | cellular response to topologically incorrect protein (GO:0035967) | 4.58101009 |
| 13 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.48593566 |
| 14 | ER-nucleus signaling pathway (GO:0006984) | 4.41201577 |
| 15 | vesicle coating (GO:0006901) | 4.34266536 |
| 16 | sequestering of metal ion (GO:0051238) | 4.22702937 |
| 17 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.13574317 |
| 18 | 4-hydroxyproline metabolic process (GO:0019471) | 3.96712043 |
| 19 | * protein N-linked glycosylation via asparagine (GO:0018279) | 3.90802644 |
| 20 | * peptidyl-asparagine modification (GO:0018196) | 3.89582126 |
| 21 | response to endoplasmic reticulum stress (GO:0034976) | 3.89142825 |
| 22 | exocrine pancreas development (GO:0031017) | 3.79013363 |
| 23 | response to unfolded protein (GO:0006986) | 3.72460262 |
| 24 | establishment of integrated proviral latency (GO:0075713) | 3.68931619 |
| 25 | nuclear pore complex assembly (GO:0051292) | 3.65101995 |
| 26 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.63373685 |
| 27 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.60651907 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.60651907 |
| 29 | response to topologically incorrect protein (GO:0035966) | 3.60197230 |
| 30 | * protein N-linked glycosylation (GO:0006487) | 3.53981290 |
| 31 | peptide hormone processing (GO:0016486) | 3.49384032 |
| 32 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.46584678 |
| 33 | protein autoprocessing (GO:0016540) | 3.33521368 |
| 34 | endocrine pancreas development (GO:0031018) | 3.31455951 |
| 35 | plasma lipoprotein particle assembly (GO:0034377) | 3.30462453 |
| 36 | peptide catabolic process (GO:0043171) | 3.27154193 |
| 37 | peptidyl-proline hydroxylation (GO:0019511) | 3.22252084 |
| 38 | proline biosynthetic process (GO:0006561) | 3.20528147 |
| 39 | nuclear pore organization (GO:0006999) | 3.15630382 |
| 40 | proline metabolic process (GO:0006560) | 3.14022652 |
| 41 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.13523502 |
| 42 | mitotic chromosome condensation (GO:0007076) | 3.11528070 |
| 43 | * SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.10726132 |
| 44 | L-serine metabolic process (GO:0006563) | 3.10275032 |
| 45 | keratan sulfate catabolic process (GO:0042340) | 3.10173137 |
| 46 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.10156888 |
| 47 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.05967797 |
| 48 | tRNA aminoacylation for protein translation (GO:0006418) | 3.05460218 |
| 49 | IMP biosynthetic process (GO:0006188) | 3.05173432 |
| 50 | establishment of viral latency (GO:0019043) | 3.05168738 |
| 51 | glandular epithelial cell differentiation (GO:0002067) | 3.02874288 |
| 52 | * protein targeting to ER (GO:0045047) | 3.02658574 |
| 53 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.01764015 |
| 54 | * cotranslational protein targeting to membrane (GO:0006613) | 2.99013725 |
| 55 | ribosome assembly (GO:0042255) | 2.98810246 |
| 56 | cell redox homeostasis (GO:0045454) | 2.95340988 |
| 57 | type B pancreatic cell development (GO:0003323) | 2.94814540 |
| 58 | formation of translation preinitiation complex (GO:0001731) | 2.93050904 |
| 59 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.91171858 |
| 60 | amino acid activation (GO:0043038) | 2.89145282 |
| 61 | tRNA aminoacylation (GO:0043039) | 2.89145282 |
| 62 | * establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.88843893 |
| 63 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.86982849 |
| 64 | apoptotic cell clearance (GO:0043277) | 2.86112830 |
| 65 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.86063492 |
| 66 | * protein localization to endoplasmic reticulum (GO:0070972) | 2.84162002 |
| 67 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.83841526 |
| 68 | protein-lipid complex assembly (GO:0065005) | 2.83445056 |
| 69 | negative regulation of fibrinolysis (GO:0051918) | 2.82443889 |
| 70 | GDP-mannose metabolic process (GO:0019673) | 2.82436875 |
| 71 | protein hydroxylation (GO:0018126) | 2.81085060 |
| 72 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.80644150 |
| 73 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.77715855 |
| 74 | regulation of cholesterol esterification (GO:0010872) | 2.75195782 |
| 75 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.74791225 |
| 76 | ER overload response (GO:0006983) | 2.74524448 |
| 77 | cellular response to vitamin D (GO:0071305) | 2.74025747 |
| 78 | chaperone-mediated protein folding (GO:0061077) | 2.72922423 |
| 79 | pore complex assembly (GO:0046931) | 2.72890339 |
| 80 | nucleobase biosynthetic process (GO:0046112) | 2.71904392 |
| 81 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.71537626 |
| 82 | negative regulation of ligase activity (GO:0051352) | 2.71537626 |
| 83 | mitotic sister chromatid segregation (GO:0000070) | 2.69606715 |
| 84 | tetrahydrofolate metabolic process (GO:0046653) | 2.69367981 |
| 85 | pentose-phosphate shunt (GO:0006098) | 2.68520965 |
| 86 | maintenance of protein localization in organelle (GO:0072595) | 2.68193564 |
| 87 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.65376891 |
| 88 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.64050418 |
| 89 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.63717488 |
| 90 | tricarboxylic acid cycle (GO:0006099) | 2.63661564 |
| 91 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.63198878 |
| 92 | protein carboxylation (GO:0018214) | 2.63198878 |
| 93 | mannose metabolic process (GO:0006013) | 2.62751817 |
| 94 | glandular epithelial cell development (GO:0002068) | 2.60874651 |
| 95 | maternal placenta development (GO:0001893) | 2.60793195 |
| 96 | cell adhesion mediated by integrin (GO:0033627) | 2.60102135 |
| 97 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.59482222 |
| 98 | regulation of translational fidelity (GO:0006450) | 2.58935257 |
| 99 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.58931014 |
| 100 | pinocytosis (GO:0006907) | 2.58211818 |
| 101 | ribosomal small subunit assembly (GO:0000028) | 2.57880048 |
| 102 | folic acid metabolic process (GO:0046655) | 2.57094496 |
| 103 | serine family amino acid biosynthetic process (GO:0009070) | 2.56634580 |
| 104 | basement membrane organization (GO:0071711) | 2.55348887 |
| 105 | telomere maintenance via recombination (GO:0000722) | 2.54893593 |
| 106 | regulation of mitochondrial translation (GO:0070129) | 2.54311472 |
| 107 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.54035011 |
| 108 | DNA unwinding involved in DNA replication (GO:0006268) | 2.53602772 |
| 109 | regulation of mitotic spindle organization (GO:0060236) | 2.53568814 |
| 110 | proteasome assembly (GO:0043248) | 2.53397245 |
| 111 | regulation of sister chromatid cohesion (GO:0007063) | 2.50704898 |
| 112 | IMP metabolic process (GO:0046040) | 2.49659624 |
| 113 | mitotic recombination (GO:0006312) | 2.47708608 |
| 114 | Golgi organization (GO:0007030) | 2.47482326 |
| 115 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.45956525 |
| 116 | non-recombinational repair (GO:0000726) | 2.45956525 |
| 117 | sister chromatid segregation (GO:0000819) | 2.45919938 |
| 118 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.45661501 |
| 119 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.44980402 |
| 120 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.44980402 |
| 121 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.44445860 |
| 122 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.43516227 |
| 123 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.43076611 |
| 124 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.43076611 |
| 125 | DNA ligation (GO:0006266) | 2.42445122 |
| 126 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.42146399 |
| 127 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.42146399 |
| 128 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.42146399 |
| 129 | biotin metabolic process (GO:0006768) | 2.41598148 |
| 130 | cholesterol biosynthetic process (GO:0006695) | 2.41332829 |
| 131 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.40924263 |
| 132 | DNA strand elongation (GO:0022616) | 2.40198240 |
| 133 | mitotic nuclear envelope disassembly (GO:0007077) | 2.37943551 |
| 134 | DNA replication initiation (GO:0006270) | 2.37779189 |
| 135 | mitotic metaphase plate congression (GO:0007080) | 2.37609786 |
| 136 | tricarboxylic acid metabolic process (GO:0072350) | 2.37281803 |
| 137 | folic acid-containing compound metabolic process (GO:0006760) | 2.36837247 |
| 138 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.36622570 |
| 139 | translesion synthesis (GO:0019985) | 2.35874561 |
| 140 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.35329080 |
| 141 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.35036307 |
| 142 | regulation of fibrinolysis (GO:0051917) | 2.34926467 |
| 143 | NADPH regeneration (GO:0006740) | 2.33809513 |
| 144 | nucleotide-sugar metabolic process (GO:0009225) | 2.32311211 |
| 145 | protein folding (GO:0006457) | 2.31939814 |
| 146 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.31606766 |
| 147 | cellular response to vitamin (GO:0071295) | 2.30612131 |
| 148 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.29568769 |
| 149 | glucose catabolic process (GO:0006007) | 2.28465386 |
| 150 | galactose catabolic process (GO:0019388) | 2.27668132 |
| 151 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.27345992 |
| 152 | intestinal epithelial cell development (GO:0060576) | 2.25842244 |
| 153 | DNA deamination (GO:0045006) | 2.24173428 |
| 154 | valine metabolic process (GO:0006573) | 2.23178630 |
| 155 | membrane disassembly (GO:0030397) | 2.23028885 |
| 156 | nuclear envelope disassembly (GO:0051081) | 2.23028885 |
| 157 | purine nucleobase biosynthetic process (GO:0009113) | 2.22701459 |
| 158 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.22133839 |
| 159 | Golgi transport vesicle coating (GO:0048200) | 10.6123927 |
| 160 | COPI coating of Golgi vesicle (GO:0048205) | 10.6123927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.20055859 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.50310158 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.99269539 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.92636779 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.51058979 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.38189285 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.31729799 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.20691748 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.18607053 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.14763475 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.13479985 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.06637120 |
| 13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.98643405 |
| 14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.96738292 |
| 15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.95524036 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.93289581 |
| 17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.91759050 |
| 18 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.89701660 |
| 19 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.89024762 |
| 20 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.88736287 |
| 21 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.88254085 |
| 22 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.88101935 |
| 23 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.81408599 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79967832 |
| 25 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.77530046 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 1.77189785 |
| 27 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.76691769 |
| 28 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.76543173 |
| 29 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.75977392 |
| 30 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.75884965 |
| 31 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.74423704 |
| 32 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.73876529 |
| 33 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73611749 |
| 34 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.72818052 |
| 35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.70499662 |
| 36 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.69923992 |
| 37 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.69745575 |
| 38 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.68682271 |
| 39 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66765756 |
| 40 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.61691653 |
| 41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.61460806 |
| 42 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.60203572 |
| 43 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.52194822 |
| 44 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.50649737 |
| 45 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48184800 |
| 46 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.45760267 |
| 47 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.41031404 |
| 48 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.40895105 |
| 49 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.40704494 |
| 50 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.38749960 |
| 51 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.38732930 |
| 52 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.38695311 |
| 53 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.37113136 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.37091417 |
| 55 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.36404379 |
| 56 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.36344547 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.34329650 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34228737 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33445800 |
| 60 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.32371654 |
| 61 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.29420315 |
| 62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.29100176 |
| 63 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.28804493 |
| 64 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.27893217 |
| 65 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.27114099 |
| 66 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.26673093 |
| 67 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.26352336 |
| 68 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.26281246 |
| 69 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.26224158 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25420580 |
| 71 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.25418327 |
| 72 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.23895794 |
| 73 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.23155376 |
| 74 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.23106120 |
| 75 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21078289 |
| 76 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.20070318 |
| 77 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.19214194 |
| 78 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19120843 |
| 79 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.18062461 |
| 80 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.16436999 |
| 81 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.16378182 |
| 82 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.16310441 |
| 83 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16302116 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15727582 |
| 85 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14292938 |
| 86 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13213164 |
| 87 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.11864410 |
| 88 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.11364574 |
| 89 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.11207138 |
| 90 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10935483 |
| 91 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.10784893 |
| 92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.10287788 |
| 93 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09896312 |
| 94 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.09258192 |
| 95 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08049922 |
| 96 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.08049668 |
| 97 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.07826790 |
| 98 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.07508149 |
| 99 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05976947 |
| 100 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04930147 |
| 101 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.04919854 |
| 102 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04758616 |
| 103 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.03922661 |
| 104 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03698556 |
| 105 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.02584645 |
| 106 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.02583742 |
| 107 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02297473 |
| 108 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02006362 |
| 109 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01245915 |
| 110 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.00655923 |
| 111 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00446814 |
| 112 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00095729 |
| 113 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.00013045 |
| 114 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99886763 |
| 115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99783789 |
| 116 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.99667432 |
| 117 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.98479159 |
| 118 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97994731 |
| 119 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.96787397 |
| 120 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.96316339 |
| 121 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.95709649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 3.56299196 |
| 2 | MP0003283_abnormal_digestive_organ | 3.46627191 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.30220804 |
| 4 | MP0006054_spinal_hemorrhage | 3.18663232 |
| 5 | MP0005220_abnormal_exocrine_pancreas | 2.47830203 |
| 6 | MP0003693_abnormal_embryo_hatching | 2.42306266 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.37592302 |
| 8 | MP0003941_abnormal_skin_development | 2.36012638 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.35512856 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 2.21566233 |
| 11 | MP0001944_abnormal_pancreas_morphology | 2.14542815 |
| 12 | MP0010030_abnormal_orbit_morphology | 2.08034994 |
| 13 | MP0004264_abnormal_extraembryonic_tissu | 2.07314968 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.06055528 |
| 15 | MP0002693_abnormal_pancreas_physiology | 1.95489746 |
| 16 | MP0000013_abnormal_adipose_tissue | 1.92529703 |
| 17 | MP0003195_calcinosis | 1.89766923 |
| 18 | MP0002909_abnormal_adrenal_gland | 1.80440169 |
| 19 | MP0004957_abnormal_blastocyst_morpholog | 1.77336986 |
| 20 | MP0003122_maternal_imprinting | 1.75940680 |
| 21 | MP0005360_urolithiasis | 1.73599173 |
| 22 | MP0000678_abnormal_parathyroid_gland | 1.71404821 |
| 23 | MP0005451_abnormal_body_composition | 1.62027760 |
| 24 | MP0003566_abnormal_cell_adhesion | 1.61823027 |
| 25 | MP0004233_abnormal_muscle_weight | 1.59449164 |
| 26 | MP0009697_abnormal_copulation | 1.56504000 |
| 27 | MP0005275_abnormal_skin_tensile | 1.54721090 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.54130333 |
| 29 | MP0005076_abnormal_cell_differentiation | 1.51004790 |
| 30 | MP0004043_abnormal_pH_regulation | 1.46603203 |
| 31 | MP0010386_abnormal_urinary_bladder | 1.46209516 |
| 32 | MP0008058_abnormal_DNA_repair | 1.45654978 |
| 33 | MP0003315_abnormal_perineum_morphology | 1.43905248 |
| 34 | MP0002896_abnormal_bone_mineralization | 1.41833612 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.39058386 |
| 36 | MP0008260_abnormal_autophagy | 1.38356086 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.36079480 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.35498416 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.33626662 |
| 40 | MP0001661_extended_life_span | 1.32117349 |
| 41 | MP0001915_intracranial_hemorrhage | 1.30581024 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 1.29988567 |
| 43 | MP0005380_embryogenesis_phenotype | 1.25870625 |
| 44 | MP0001672_abnormal_embryogenesis/_devel | 1.25870625 |
| 45 | MP0001849_ear_inflammation | 1.25753409 |
| 46 | MP0000566_synostosis | 1.25645639 |
| 47 | MP0004272_abnormal_basement_membrane | 1.25416751 |
| 48 | MP0003950_abnormal_plasma_membrane | 1.25297371 |
| 49 | MP0010307_abnormal_tumor_latency | 1.25004505 |
| 50 | MP0008007_abnormal_cellular_replicative | 1.24980472 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 1.24458706 |
| 52 | MP0005023_abnormal_wound_healing | 1.21354507 |
| 53 | MP0005503_abnormal_tendon_morphology | 1.18567655 |
| 54 | MP0001666_abnormal_nutrient_absorption | 1.17101906 |
| 55 | MP0003718_maternal_effect | 1.16815008 |
| 56 | MP0000490_abnormal_crypts_of | 1.13489387 |
| 57 | MP0002938_white_spotting | 1.11626579 |
| 58 | MP0004858_abnormal_nervous_system | 1.10059882 |
| 59 | MP0001756_abnormal_urination | 1.09893238 |
| 60 | MP0009840_abnormal_foam_cell | 1.09657774 |
| 61 | MP0005501_abnormal_skin_physiology | 1.09650783 |
| 62 | MP0000462_abnormal_digestive_system | 1.06828190 |
| 63 | MP0008875_abnormal_xenobiotic_pharmacok | 1.06746131 |
| 64 | MP0000003_abnormal_adipose_tissue | 1.06509863 |
| 65 | MP0003111_abnormal_nucleus_morphology | 1.05974402 |
| 66 | MP0002089_abnormal_postnatal_growth/wei | 1.05440041 |
| 67 | MP0001730_embryonic_growth_arrest | 1.04511912 |
| 68 | MP0009384_cardiac_valve_regurgitation | 1.04187641 |
| 69 | MP0000627_abnormal_mammary_gland | 1.02590900 |
| 70 | MP0001881_abnormal_mammary_gland | 1.01892656 |
| 71 | MP0005197_abnormal_uvea_morphology | 1.01606688 |
| 72 | MP0000613_abnormal_salivary_gland | 1.01537056 |
| 73 | MP0004782_abnormal_surfactant_physiolog | 1.00517690 |
| 74 | MP0002697_abnormal_eye_size | 1.00465935 |
| 75 | MP0005171_absent_coat_pigmentation | 0.99533884 |
| 76 | MP0003077_abnormal_cell_cycle | 0.98599462 |
| 77 | MP0003795_abnormal_bone_structure | 0.97215005 |
| 78 | MP0002085_abnormal_embryonic_tissue | 0.96817495 |
| 79 | MP0002078_abnormal_glucose_homeostasis | 0.96353600 |
| 80 | MP0005365_abnormal_bile_salt | 0.96059469 |
| 81 | MP0002084_abnormal_developmental_patter | 0.95695527 |
| 82 | MP0003123_paternal_imprinting | 0.92978866 |
| 83 | MP0003942_abnormal_urinary_system | 0.92729373 |
| 84 | MP0002060_abnormal_skin_morphology | 0.91888947 |
| 85 | MP0002796_impaired_skin_barrier | 0.91515148 |
| 86 | MP0000762_abnormal_tongue_morphology | 0.91446349 |
| 87 | MP0001533_abnormal_skeleton_physiology | 0.90512523 |
| 88 | MP0000537_abnormal_urethra_morphology | 0.89765767 |
| 89 | MP0005257_abnormal_intraocular_pressure | 0.89383773 |
| 90 | MP0000858_altered_metastatic_potential | 0.88776091 |
| 91 | MP0001958_emphysema | 0.88173029 |
| 92 | MP0003385_abnormal_body_wall | 0.87744310 |
| 93 | MP0001346_abnormal_lacrimal_gland | 0.87721806 |
| 94 | MP0001243_abnormal_dermal_layer | 0.87560018 |
| 95 | MP0003806_abnormal_nucleotide_metabolis | 0.87416594 |
| 96 | MP0002396_abnormal_hematopoietic_system | 0.86710732 |
| 97 | MP0001216_abnormal_epidermal_layer | 0.86124802 |
| 98 | MP0010094_abnormal_chromosome_stability | 0.85509924 |
| 99 | MP0003866_abnormal_defecation | 0.85420669 |
| 100 | MP0002098_abnormal_vibrissa_morphology | 0.84660640 |
| 101 | MP0010329_abnormal_lipoprotein_level | 0.84165846 |
| 102 | MP0002933_joint_inflammation | 0.83926386 |
| 103 | MP0005083_abnormal_biliary_tract | 0.83854303 |
| 104 | MP0005379_endocrine/exocrine_gland_phen | 0.83813733 |
| 105 | MP0003252_abnormal_bile_duct | 0.83774553 |
| 106 | MP0004197_abnormal_fetal_growth/weight/ | 0.83699949 |
| 107 | MP0005623_abnormal_meninges_morphology | 0.83422433 |
| 108 | MP0000358_abnormal_cell_content/ | 0.82871168 |
| 109 | MP0005384_cellular_phenotype | 0.82296015 |
| 110 | MP0002080_prenatal_lethality | 0.80999152 |
| 111 | MP0002928_abnormal_bile_duct | 0.79877942 |
| 112 | MP0000598_abnormal_liver_morphology | 0.79870554 |
| 113 | MP0003279_aneurysm | 0.79349216 |
| 114 | MP0004808_abnormal_hematopoietic_stem | 0.79319078 |
| 115 | MP0009672_abnormal_birth_weight | 0.79277690 |
| 116 | MP0003786_premature_aging | 0.79053307 |
| 117 | MP0010368_abnormal_lymphatic_system | 0.78582037 |
| 118 | MP0002092_abnormal_eye_morphology | 0.78145677 |
| 119 | MP0003115_abnormal_respiratory_system | 0.77632201 |
| 120 | MP0001765_abnormal_ion_homeostasis | 0.77495618 |
| 121 | MP0003937_abnormal_limbs/digits/tail_de | 0.76890183 |
| 122 | MP0002166_altered_tumor_susceptibility | 0.76476923 |
| 123 | MP0000681_abnormal_thyroid_gland | 0.75232814 |
| 124 | MP0000467_abnormal_esophagus_morphology | 0.74874230 |
| 125 | MP0008932_abnormal_embryonic_tissue | 0.74636962 |
| 126 | MP0005621_abnormal_cell_physiology | 0.74151224 |
| 127 | MP0009333_abnormal_splenocyte_physiolog | 0.73963355 |
| 128 | MP0005636_abnormal_mineral_homeostasis | 0.73895502 |
| 129 | MP0001697_abnormal_embryo_size | 0.73660876 |
| 130 | MP0002295_abnormal_pulmonary_circulatio | 0.73548230 |
| 131 | MP0002233_abnormal_nose_morphology | 0.73418522 |
| 132 | MP0002234_abnormal_pharynx_morphology | 0.73329269 |
| 133 | MP0000350_abnormal_cell_proliferation | 0.72925269 |
| 134 | MP0000477_abnormal_intestine_morphology | 0.72314134 |
| 135 | MP0005165_increased_susceptibility_to | 0.72267199 |
| 136 | MP0005508_abnormal_skeleton_morphology | 0.72216789 |
| 137 | MP0005408_hypopigmentation | 0.71456897 |
| 138 | MP0000163_abnormal_cartilage_morphology | 0.71240361 |
| 139 | MP0002111_abnormal_tail_morphology | 0.70319756 |
| 140 | MP0000609_abnormal_liver_physiology | 0.70277836 |
| 141 | MP0000465_gastrointestinal_hemorrhage | 0.70249146 |
| 142 | MP0000428_abnormal_craniofacial_morphol | 0.68798000 |
| 143 | MP0001270_distended_abdomen | 0.68680345 |
| 144 | MP0002086_abnormal_extraembryonic_tissu | 0.68023621 |
| 145 | MP0005390_skeleton_phenotype | 0.67806399 |
| 146 | MP0003186_abnormal_redox_activity | 0.67514607 |
| 147 | MP0001919_abnormal_reproductive_system | 0.66787928 |
| 148 | MP0003984_embryonic_growth_retardation | 0.66495958 |
| 149 | MP0002135_abnormal_kidney_morphology | 0.66245657 |
| 150 | MP0002088_abnormal_embryonic_growth/wei | 0.65544909 |
| 151 | MP0003436_decreased_susceptibility_to | 0.65448994 |
| 152 | MP0003868_abnormal_feces_composition | 0.64188498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.37291009 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.26156193 |
| 3 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.14384401 |
| 4 | Hypoglycemic seizures (HP:0002173) | 3.98148727 |
| 5 | Cervical subluxation (HP:0003308) | 3.87119459 |
| 6 | Mucopolysacchariduria (HP:0008155) | 3.81382038 |
| 7 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.81382038 |
| 8 | Abnormality of glycolysis (HP:0004366) | 3.78195198 |
| 9 | Dysostosis multiplex (HP:0000943) | 3.70231001 |
| 10 | Increased serum pyruvate (HP:0003542) | 3.46194408 |
| 11 | Protrusio acetabuli (HP:0003179) | 3.34811253 |
| 12 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.33318888 |
| 13 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.33318888 |
| 14 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.33318888 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 3.32610570 |
| 16 | Symptomatic seizures (HP:0011145) | 3.24683766 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 3.20268890 |
| 18 | 11 pairs of ribs (HP:0000878) | 3.14771555 |
| 19 | Beaking of vertebral bodies (HP:0004568) | 3.13873031 |
| 20 | Premature rupture of membranes (HP:0001788) | 3.08675152 |
| 21 | Abnormality of the intrinsic pathway (HP:0010989) | 3.06763199 |
| 22 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.01083520 |
| 23 | Abnormal gallbladder physiology (HP:0012438) | 3.00568696 |
| 24 | Cholecystitis (HP:0001082) | 3.00568696 |
| 25 | Abnormality of carpal bone ossification (HP:0006257) | 2.98608033 |
| 26 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.92577714 |
| 27 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.92577714 |
| 28 | Late onset (HP:0003584) | 2.85729075 |
| 29 | Thoracolumbar scoliosis (HP:0002944) | 2.84163680 |
| 30 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.81375153 |
| 31 | Small epiphyses (HP:0010585) | 2.70328292 |
| 32 | Missing ribs (HP:0000921) | 2.70118208 |
| 33 | Microvesicular hepatic steatosis (HP:0001414) | 2.67595528 |
| 34 | Abnormality of the anterior horn cell (HP:0006802) | 2.63151443 |
| 35 | Degeneration of anterior horn cells (HP:0002398) | 2.63151443 |
| 36 | Cerebral aneurysm (HP:0004944) | 2.62383480 |
| 37 | Hyperglycemia (HP:0003074) | 2.59666808 |
| 38 | Thrombocytosis (HP:0001894) | 2.57225589 |
| 39 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.55527524 |
| 40 | Metaphyseal cupping (HP:0003021) | 2.52681571 |
| 41 | Abnormality of dentin (HP:0010299) | 2.52573299 |
| 42 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.52043275 |
| 43 | Prolonged partial thromboplastin time (HP:0003645) | 2.50376818 |
| 44 | Severe short stature (HP:0003510) | 2.47725498 |
| 45 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.47452068 |
| 46 | Abnormal protein glycosylation (HP:0012346) | 2.44107182 |
| 47 | Abnormal glycosylation (HP:0012345) | 2.44107182 |
| 48 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.44107182 |
| 49 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.44107182 |
| 50 | Insulin resistance (HP:0000855) | 2.43946120 |
| 51 | Abnormal pancreas size (HP:0012094) | 2.43485386 |
| 52 | Abnormal delivery (HP:0001787) | 2.43406957 |
| 53 | Short nail (HP:0001799) | 2.41828264 |
| 54 | Large for gestational age (HP:0001520) | 2.41241771 |
| 55 | Ketoacidosis (HP:0001993) | 2.40991445 |
| 56 | Hand muscle atrophy (HP:0009130) | 2.38689702 |
| 57 | Hypolipoproteinemia (HP:0010981) | 2.38526353 |
| 58 | Chromsome breakage (HP:0040012) | 2.36180227 |
| 59 | Asymmetry of the thorax (HP:0001555) | 2.36059835 |
| 60 | Platyspondyly (HP:0000926) | 2.30948894 |
| 61 | Abnormality of the calcaneus (HP:0008364) | 2.28947514 |
| 62 | Nonimmune hydrops fetalis (HP:0001790) | 2.28154025 |
| 63 | Joint stiffness (HP:0001387) | 2.27863924 |
| 64 | Ankle contracture (HP:0006466) | 2.27323906 |
| 65 | Increased cerebral lipofuscin (HP:0011813) | 2.26494583 |
| 66 | Absent epiphyses (HP:0010577) | 2.24413189 |
| 67 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.24413189 |
| 68 | Abnormality of the common coagulation pathway (HP:0010990) | 2.24216621 |
| 69 | Abnormal foot bone ossification (HP:0010675) | 2.20903311 |
| 70 | Deviation of the thumb (HP:0009603) | 2.19818733 |
| 71 | Abnormal ossification of hand bones (HP:0005921) | 2.19432195 |
| 72 | Type I transferrin isoform profile (HP:0003642) | 2.17052978 |
| 73 | Microglossia (HP:0000171) | 2.16901604 |
| 74 | Overlapping toe (HP:0001845) | 2.16688775 |
| 75 | Renal duplication (HP:0000075) | 2.15625902 |
| 76 | Abnormality of the acetabulum (HP:0003170) | 2.15438278 |
| 77 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.12466003 |
| 78 | Generalized aminoaciduria (HP:0002909) | 2.11465065 |
| 79 | Trismus (HP:0000211) | 2.10034229 |
| 80 | Abdominal distention (HP:0003270) | 2.09170953 |
| 81 | Increased nuchal translucency (HP:0010880) | 2.06991641 |
| 82 | Abnormality of methionine metabolism (HP:0010901) | 2.05746602 |
| 83 | Pterygium (HP:0001059) | 2.05137425 |
| 84 | Proximal placement of thumb (HP:0009623) | 2.01469575 |
| 85 | Hypercholesterolemia (HP:0003124) | 1.99210676 |
| 86 | Protuberant abdomen (HP:0001538) | 1.98414096 |
| 87 | Unilateral renal agenesis (HP:0000122) | 1.97596775 |
| 88 | Abnormal cartilage morphology (HP:0002763) | 1.97478184 |
| 89 | Prominent metopic ridge (HP:0005487) | 1.95936397 |
| 90 | Soft skin (HP:0000977) | 1.95164705 |
| 91 | Abnormal hand bone ossification (HP:0010660) | 1.95092273 |
| 92 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.91060799 |
| 93 | Abnormality of glycolipid metabolism (HP:0010969) | 1.91060799 |
| 94 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.91060799 |
| 95 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.90826685 |
| 96 | Vertebral hypoplasia (HP:0008417) | 1.90826685 |
| 97 | Vascular calcification (HP:0004934) | 1.89952889 |
| 98 | Hypoplasia of the odontoid process (HP:0003311) | 1.89776064 |
| 99 | Multiple enchondromatosis (HP:0005701) | 1.89478775 |
| 100 | Ovoid vertebral bodies (HP:0003300) | 1.89282843 |
| 101 | Reduced antithrombin III activity (HP:0001976) | 1.89213334 |
| 102 | Broad face (HP:0000283) | 1.87902791 |
| 103 | Disproportionate short-trunk short stature (HP:0003521) | 1.87121593 |
| 104 | Epiphyseal dysplasia (HP:0002656) | 1.86894895 |
| 105 | Aortic dissection (HP:0002647) | 1.86596732 |
| 106 | Entropion (HP:0000621) | 1.85707102 |
| 107 | Abnormality of the umbilical cord (HP:0010881) | 1.85248599 |
| 108 | Spastic paraparesis (HP:0002313) | 1.84382908 |
| 109 | Hyperparathyroidism (HP:0000843) | 1.83941768 |
| 110 | Cardiovascular calcification (HP:0011915) | 1.83708467 |
| 111 | Progressive muscle weakness (HP:0003323) | 1.83668424 |
| 112 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.83388125 |
| 113 | Abnormality of the Achilles tendon (HP:0005109) | 1.83134878 |
| 114 | Intrahepatic cholestasis (HP:0001406) | 1.83093275 |
| 115 | Ulnar deviation of the wrist (HP:0003049) | 1.82999407 |
| 116 | Poor head control (HP:0002421) | 1.82431584 |
| 117 | Gout (HP:0001997) | 1.81162269 |
| 118 | Vertebral compression fractures (HP:0002953) | 1.80719114 |
| 119 | Progressive neurologic deterioration (HP:0002344) | 1.80461202 |
| 120 | Right ventricular cardiomyopathy (HP:0011663) | 1.80381597 |
| 121 | Secondary amenorrhea (HP:0000869) | 1.79742337 |
| 122 | Spondylolisthesis (HP:0003302) | 1.79014071 |
| 123 | Hypokinesia (HP:0002375) | 1.78212975 |
| 124 | Aneurysm (HP:0002617) | 1.78045186 |
| 125 | Spinal cord compression (HP:0002176) | 1.77647226 |
| 126 | Septate vagina (HP:0001153) | 1.77102504 |
| 127 | Abnormal tarsal ossification (HP:0008369) | 1.76439113 |
| 128 | Aortic aneurysm (HP:0004942) | 1.75828679 |
| 129 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.75748559 |
| 130 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.75720132 |
| 131 | Sparse eyelashes (HP:0000653) | 1.75304519 |
| 132 | Blue sclerae (HP:0000592) | 1.74437557 |
| 133 | Hyperammonemia (HP:0001987) | 1.74138520 |
| 134 | Villous atrophy (HP:0011473) | 1.73845023 |
| 135 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.73845023 |
| 136 | Elbow flexion contracture (HP:0002987) | 1.73775736 |
| 137 | Flat acetabular roof (HP:0003180) | 1.73053771 |
| 138 | Breech presentation (HP:0001623) | 1.73030120 |
| 139 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.71782438 |
| 140 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.71689219 |
| 141 | Irregular vertebral endplates (HP:0003301) | 1.71171906 |
| 142 | Coxa valga (HP:0002673) | 1.70717555 |
| 143 | Long toe (HP:0010511) | 1.70025783 |
| 144 | Meckel diverticulum (HP:0002245) | 1.69488098 |
| 145 | Rough bone trabeculation (HP:0100670) | 1.69256879 |
| 146 | Broad palm (HP:0001169) | 1.67850389 |
| 147 | Back pain (HP:0003418) | 1.67718555 |
| 148 | Selective tooth agenesis (HP:0001592) | 1.66813031 |
| 149 | Abnormality of the odontoid process (HP:0003310) | 1.66561829 |
| 150 | Abnormal biliary tract morphology (HP:0012440) | 1.66457278 |
| 151 | Rhizomelia (HP:0008905) | 1.64872642 |
| 152 | Xanthomatosis (HP:0000991) | 1.64704212 |
| 153 | Hypoplasia of the pons (HP:0012110) | 1.64633271 |
| 154 | Hypoalphalipoproteinemia (HP:0003233) | 1.64075655 |
| 155 | Orthostatic hypotension (HP:0001278) | 1.64029561 |
| 156 | Spastic diplegia (HP:0001264) | 1.63963354 |
| 157 | Aplastic anemia (HP:0001915) | 1.63961515 |
| 158 | Hyperacusis (HP:0010780) | 1.63857954 |
| 159 | Dilatation of the ascending aorta (HP:0005111) | 1.63691259 |
| 160 | Distal upper limb amyotrophy (HP:0007149) | 1.63548807 |
| 161 | Upper limb amyotrophy (HP:0009129) | 1.63548807 |
| 162 | Facial cleft (HP:0002006) | 1.60725710 |
| 163 | Deep philtrum (HP:0002002) | 1.60042012 |
| 164 | Achilles tendon contracture (HP:0001771) | 1.60005435 |
| 165 | Broad alveolar ridges (HP:0000187) | 1.59884696 |
| 166 | Ulnar bowing (HP:0003031) | 1.59735604 |
| 167 | Cupped ribs (HP:0000887) | 1.59036862 |
| 168 | Natal tooth (HP:0000695) | 1.58613127 |
| 169 | Coxa vara (HP:0002812) | 1.58426056 |
| 170 | Limited elbow extension (HP:0001377) | 1.58046273 |
| 171 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.58040524 |
| 172 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.56655346 |
| 173 | Abnormality of pain sensation (HP:0010832) | 1.56513876 |
| 174 | Impaired pain sensation (HP:0007328) | 1.56513876 |
| 175 | Wormian bones (HP:0002645) | 1.56221225 |
| 176 | Spontaneous abortion (HP:0005268) | 1.55871409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PASK | 4.38441759 |
| 2 | ERN1 | 3.75794123 |
| 3 | PBK | 3.74634556 |
| 4 | TRIB3 | 2.98818703 |
| 5 | SCYL2 | 2.92940265 |
| 6 | VRK2 | 2.38857029 |
| 7 | TAOK3 | 2.30727734 |
| 8 | PKN2 | 2.27498941 |
| 9 | IRAK3 | 2.26778747 |
| 10 | INSRR | 2.22292047 |
| 11 | FLT3 | 2.21074417 |
| 12 | SRPK1 | 2.20472290 |
| 13 | BRSK2 | 2.18331060 |
| 14 | TESK1 | 2.17838666 |
| 15 | SMG1 | 2.11741707 |
| 16 | EPHA2 | 2.11140213 |
| 17 | BUB1 | 2.06372931 |
| 18 | PDK2 | 1.98793429 |
| 19 | EEF2K | 1.97879846 |
| 20 | BCKDK | 1.96525587 |
| 21 | WEE1 | 1.91107332 |
| 22 | ICK | 1.74396423 |
| 23 | EIF2AK3 | 1.73884656 |
| 24 | TESK2 | 1.72548311 |
| 25 | SIK1 | 1.55648985 |
| 26 | MAPK15 | 1.49603283 |
| 27 | FRK | 1.49383844 |
| 28 | PAK4 | 1.44697337 |
| 29 | ERBB4 | 1.44592901 |
| 30 | CDK12 | 1.42668501 |
| 31 | PDGFRA | 1.41629823 |
| 32 | PTK6 | 1.40231216 |
| 33 | LRRK2 | 1.32541444 |
| 34 | PLK3 | 1.27450322 |
| 35 | NEK2 | 1.24167659 |
| 36 | TSSK6 | 1.23446165 |
| 37 | EIF2AK1 | 1.22636656 |
| 38 | RPS6KA4 | 1.19466983 |
| 39 | MAP3K3 | 1.19378279 |
| 40 | STK16 | 1.19049263 |
| 41 | RPS6KB2 | 1.15790453 |
| 42 | TGFBR1 | 1.15726412 |
| 43 | LMTK2 | 1.12591354 |
| 44 | CDC7 | 1.09227668 |
| 45 | CDK8 | 1.08921963 |
| 46 | NME2 | 1.07019457 |
| 47 | HIPK2 | 1.05701442 |
| 48 | KDR | 1.04258604 |
| 49 | LATS2 | 1.01591920 |
| 50 | MST4 | 0.99582624 |
| 51 | MAP3K12 | 0.99501312 |
| 52 | MAP3K2 | 0.99186716 |
| 53 | RIPK1 | 0.97102530 |
| 54 | TTN | 0.96445815 |
| 55 | MAP3K8 | 0.95454746 |
| 56 | PAK2 | 0.94540108 |
| 57 | PTK2 | 0.93618236 |
| 58 | MAPKAPK3 | 0.92917879 |
| 59 | ZAP70 | 0.92397261 |
| 60 | MAP2K3 | 0.91666340 |
| 61 | TRIM28 | 0.90934642 |
| 62 | MAP2K2 | 0.90599209 |
| 63 | STK10 | 0.89780761 |
| 64 | MET | 0.88514494 |
| 65 | FGFR1 | 0.87529360 |
| 66 | NEK1 | 0.85925676 |
| 67 | BCR | 0.84646102 |
| 68 | JAK3 | 0.83761982 |
| 69 | PLK4 | 0.82393093 |
| 70 | ACVR1B | 0.79418372 |
| 71 | PIK3CG | 0.78515546 |
| 72 | TTK | 0.78008210 |
| 73 | DDR2 | 0.77831871 |
| 74 | MAP3K10 | 0.77340687 |
| 75 | PIM2 | 0.76801195 |
| 76 | ARAF | 0.75256144 |
| 77 | CHEK2 | 0.74990654 |
| 78 | DYRK1B | 0.74649022 |
| 79 | PRKD3 | 0.74596946 |
| 80 | AURKB | 0.73615472 |
| 81 | BRSK1 | 0.73451852 |
| 82 | EPHA3 | 0.72517123 |
| 83 | NME1 | 0.71198108 |
| 84 | IRAK1 | 0.68082783 |
| 85 | ATR | 0.68031347 |
| 86 | MTOR | 0.67364617 |
| 87 | BTK | 0.65950180 |
| 88 | NEK9 | 0.64164717 |
| 89 | IRAK4 | 0.61751376 |
| 90 | FGFR4 | 0.61654320 |
| 91 | CAMKK2 | 0.61443107 |
| 92 | NTRK1 | 0.60115329 |
| 93 | CDK7 | 0.59790002 |
| 94 | PRKCI | 0.58521430 |
| 95 | WNK4 | 0.58420664 |
| 96 | TGFBR2 | 0.57705642 |
| 97 | DAPK1 | 0.57609803 |
| 98 | MAPK11 | 0.56671014 |
| 99 | FGFR3 | 0.56215578 |
| 100 | LATS1 | 0.54145407 |
| 101 | FER | 0.53641514 |
| 102 | PLK1 | 0.52864682 |
| 103 | TEC | 0.52595844 |
| 104 | MAP3K1 | 0.50901847 |
| 105 | AKT2 | 0.49429783 |
| 106 | MKNK1 | 0.47408102 |
| 107 | STK3 | 0.47002837 |
| 108 | ILK | 0.46957131 |
| 109 | EIF2AK2 | 0.46919863 |
| 110 | ABL2 | 0.45694592 |
| 111 | DYRK3 | 0.45475560 |
| 112 | AKT3 | 0.45463666 |
| 113 | CSNK2A1 | 0.44051381 |
| 114 | CSNK2A2 | 0.43199987 |
| 115 | ATM | 0.42311482 |
| 116 | CDK18 | 0.42024424 |
| 117 | CDK9 | 0.41631788 |
| 118 | SIK3 | 0.41502064 |
| 119 | TYK2 | 0.41388628 |
| 120 | TBK1 | 0.40585925 |
| 121 | ZAK | 0.40338600 |
| 122 | TAF1 | 0.39993172 |
| 123 | JAK2 | 0.39771124 |
| 124 | LIMK1 | 0.39744084 |
| 125 | CLK1 | 0.39721501 |
| 126 | ITK | 0.39649986 |
| 127 | CDK4 | 0.39354811 |
| 128 | PAK1 | 0.38054543 |
| 129 | CDK15 | 0.37753082 |
| 130 | CDK14 | 0.37422646 |
| 131 | CDK1 | 0.37272140 |
| 132 | AURKA | 0.36406338 |
| 133 | CSNK1G3 | 0.36201432 |
| 134 | EPHB1 | 0.35935877 |
| 135 | BMX | 0.35518762 |
| 136 | CHEK1 | 0.34703284 |
| 137 | PDK4 | 0.33629635 |
| 138 | PDK3 | 0.33629635 |
| 139 | CDK6 | 0.33515400 |
| 140 | VRK1 | 0.32507511 |
| 141 | MST1R | 0.32278454 |
| 142 | MAP3K11 | 0.29358725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.23499678 |
| 2 | Protein export_Homo sapiens_hsa03060 | 5.12269609 |
| 3 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 4.07441861 |
| 4 | * N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.56150577 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.45107196 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.43698151 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.35941347 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.31268607 |
| 9 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.30508901 |
| 10 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.16963578 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.15336069 |
| 12 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.11131029 |
| 13 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.02370436 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.00560556 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 1.90813805 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.87286127 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.77836208 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.73535484 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.72497261 |
| 20 | Galactose metabolism_Homo sapiens_hsa00052 | 1.61160252 |
| 21 | Mismatch repair_Homo sapiens_hsa03430 | 1.59525061 |
| 22 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.51909356 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.50625982 |
| 24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.47396591 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.46497005 |
| 26 | Proteasome_Homo sapiens_hsa03050 | 1.45217513 |
| 27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.38388904 |
| 28 | RNA transport_Homo sapiens_hsa03013 | 1.30091358 |
| 29 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.21038419 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.16204514 |
| 31 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.15978441 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.14929686 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.13432811 |
| 34 | Cell cycle_Homo sapiens_hsa04110 | 1.10699481 |
| 35 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.05897123 |
| 36 | Spliceosome_Homo sapiens_hsa03040 | 1.05800718 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04323051 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04175591 |
| 39 | Ribosome_Homo sapiens_hsa03010 | 1.02519167 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02135896 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99972234 |
| 42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.98331490 |
| 43 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.98329598 |
| 44 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96981298 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93009713 |
| 46 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.90939739 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86008402 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.85709058 |
| 49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.84677727 |
| 50 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.84029553 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82564676 |
| 52 | Bladder cancer_Homo sapiens_hsa05219 | 0.82279063 |
| 53 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.82129672 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81509693 |
| 55 | Homologous recombination_Homo sapiens_hsa03440 | 0.79862967 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77582627 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76569172 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75295223 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74439733 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70888562 |
| 61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68570113 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66223097 |
| 63 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65948519 |
| 64 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64563840 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64441244 |
| 66 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.64174493 |
| 67 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63547494 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63315844 |
| 69 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61478555 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61393621 |
| 71 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.61168298 |
| 72 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59455328 |
| 73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58972035 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.58237013 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57486453 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55998455 |
| 77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.55997525 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54995074 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.53734716 |
| 80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53308993 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53134987 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.51766166 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51547469 |
| 84 | RNA polymerase_Homo sapiens_hsa03020 | 0.50892922 |
| 85 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.50160536 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.49074357 |
| 87 | Focal adhesion_Homo sapiens_hsa04510 | 0.48208401 |
| 88 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47539899 |
| 89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46101072 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45299097 |
| 91 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44574357 |
| 92 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44228265 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.44060118 |
| 94 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.43205672 |
| 95 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42778776 |
| 96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42156882 |
| 97 | Purine metabolism_Homo sapiens_hsa00230 | 0.41602641 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39879819 |
| 99 | Phagosome_Homo sapiens_hsa04145 | 0.39827486 |
| 100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39698544 |
| 101 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.39505999 |
| 102 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.38564591 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37648674 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36441778 |
| 105 | Lysine degradation_Homo sapiens_hsa00310 | 0.35278324 |
| 106 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35249128 |
| 107 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.35215245 |
| 108 | Apoptosis_Homo sapiens_hsa04210 | 0.34370305 |
| 109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33847924 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.33761539 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32499467 |
| 112 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.31116533 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.30698656 |
| 114 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.30141711 |
| 115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29717377 |
| 116 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.29434543 |
| 117 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.29024336 |
| 118 | RNA degradation_Homo sapiens_hsa03018 | 0.27305991 |
| 119 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.26764371 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.26754577 |
| 121 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.26409734 |
| 122 | Adherens junction_Homo sapiens_hsa04520 | 0.25888709 |
| 123 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.25135398 |
| 124 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.24711265 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | 0.23691183 |
| 126 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23645612 |

